Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-063292

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael S Hearne
Officer — Chief Financial Officer
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 14, 2018A42$12.85A673D
Common StockF2holding———12,822,338IBy LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$15.12Dec 14, 2018A42A—Dec 14, 2028Common Stock4242D

Explanation of responses